iBio (IBIO) Profit After Tax (2010 - 2026)

iBio (IBIO) has reported Profit After Tax for 17 consecutive years, with -$7.7 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Profit After Tax fell 59.02% year-over-year to -$7.7 million; the TTM figure through Mar 2026 stood at -$27.6 million (down 31.51% YoY), while the FY2025 annual figure was -$18.4 million, up 26.22% from the prior year.
• Profit After Tax climbed to -$7.7 million in Q1 2026 per IBIO's latest filing, from -$9.0 million in the prior quarter.
• Across five years, Profit After Tax topped out at -$3.2 million in Q1 2024 and bottomed at -$40.6 million in Q2 2023.
• Historically, Profit After Tax has averaged -$10.7 million across 5 years, with a median of -$6.7 million in 2022.
• Annual changes were most pronounced in 2022 — Profit After Tax plunged 9211.4% — and 2024, when it soared 80.86%.
• iBio's Profit After Tax stood at -$33.6 million in 2022, then soared by 75.53% to -$8.2 million in 2023, then jumped by 46.85% to -$4.4 million in 2024, then sank by 106.07% to -$9.0 million in 2025, then gained by 14.04% to -$7.7 million in 2026.
• Business Quant data shows IBIO's Profit After Tax at -$7.7 million in Q1 2026, -$9.0 million in Q4 2025, and -$5.7 million in Q3 2025.